A PHP Error was encountered

Severity: Warning

Message: fopen(/var/cpanel/php/sessions/ea-php72/ci_session5ffbb9369652f08ff2c0958e23752efef074874b): failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 176

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/cpanel/php/sessions/ea-php72)

Filename: Session/Session.php

Line Number: 143

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

Global Bronchiectasis Therapeutic Market Research Report 2024

img

Global Bronchiectasis Therapeutic Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Bronchiectasis Therapeutic Market Research Report 2024

According to MRAResearch’s new survey, global Bronchiectasis Therapeutic market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Bronchiectasis Therapeutic market research.
Key companies engaged in the Bronchiectasis Therapeutic industry include GlaxoSmithKline, Alitair Pharmaceuticals Inc., Bayer AG, Chiesi Farmaceutici SpA, Grifols SA, Insmed Inc, Kamada Ltd, Polyphor Ltd and Recipharm AB, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Bronchiectasis Therapeutic were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Bronchiectasis Therapeutic market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Bronchiectasis Therapeutic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


GlaxoSmithKline
Alitair Pharmaceuticals Inc.
Bayer AG
Chiesi Farmaceutici SpA
Grifols SA
Insmed Inc
Kamada Ltd
Polyphor Ltd
Recipharm AB
Segment by Type
Antibiotics
Expectorants
Others

Segment by Application


Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Bronchiectasis Therapeutic report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bronchiectasis Therapeutic Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Antibiotics
1.2.3 Expectorants
1.2.4 Others
1.3 Market by Application
1.3.1 Global Bronchiectasis Therapeutic Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bronchiectasis Therapeutic Market Perspective (2018-2033)
2.2 Bronchiectasis Therapeutic Growth Trends by Region
2.2.1 Global Bronchiectasis Therapeutic Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Bronchiectasis Therapeutic Historic Market Size by Region (2018-2023)
2.2.3 Bronchiectasis Therapeutic Forecasted Market Size by Region (2024-2033)
2.3 Bronchiectasis Therapeutic Market Dynamics
2.3.1 Bronchiectasis Therapeutic Industry Trends
2.3.2 Bronchiectasis Therapeutic Market Drivers
2.3.3 Bronchiectasis Therapeutic Market Challenges
2.3.4 Bronchiectasis Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bronchiectasis Therapeutic Players by Revenue
3.1.1 Global Top Bronchiectasis Therapeutic Players by Revenue (2018-2023)
3.1.2 Global Bronchiectasis Therapeutic Revenue Market Share by Players (2018-2023)
3.2 Global Bronchiectasis Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bronchiectasis Therapeutic Revenue
3.4 Global Bronchiectasis Therapeutic Market Concentration Ratio
3.4.1 Global Bronchiectasis Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bronchiectasis Therapeutic Revenue in 2022
3.5 Bronchiectasis Therapeutic Key Players Head office and Area Served
3.6 Key Players Bronchiectasis Therapeutic Product Solution and Service
3.7 Date of Enter into Bronchiectasis Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bronchiectasis Therapeutic Breakdown Data by Type
4.1 Global Bronchiectasis Therapeutic Historic Market Size by Type (2018-2023)
4.2 Global Bronchiectasis Therapeutic Forecasted Market Size by Type (2024-2033)
5 Bronchiectasis Therapeutic Breakdown Data by Application
5.1 Global Bronchiectasis Therapeutic Historic Market Size by Application (2018-2023)
5.2 Global Bronchiectasis Therapeutic Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Bronchiectasis Therapeutic Market Size (2018-2033)
6.2 North America Bronchiectasis Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Bronchiectasis Therapeutic Market Size by Country (2018-2023)
6.4 North America Bronchiectasis Therapeutic Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bronchiectasis Therapeutic Market Size (2018-2033)
7.2 Europe Bronchiectasis Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Bronchiectasis Therapeutic Market Size by Country (2018-2023)
7.4 Europe Bronchiectasis Therapeutic Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bronchiectasis Therapeutic Market Size (2018-2033)
8.2 Asia-Pacific Bronchiectasis Therapeutic Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Bronchiectasis Therapeutic Market Size by Region (2018-2023)
8.4 Asia-Pacific Bronchiectasis Therapeutic Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bronchiectasis Therapeutic Market Size (2018-2033)
9.2 Latin America Bronchiectasis Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Bronchiectasis Therapeutic Market Size by Country (2018-2023)
9.4 Latin America Bronchiectasis Therapeutic Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bronchiectasis Therapeutic Market Size (2018-2033)
10.2 Middle East & Africa Bronchiectasis Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Bronchiectasis Therapeutic Market Size by Country (2018-2023)
10.4 Middle East & Africa Bronchiectasis Therapeutic Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Bronchiectasis Therapeutic Introduction
11.1.4 GlaxoSmithKline Revenue in Bronchiectasis Therapeutic Business (2018-2023)
11.1.5 GlaxoSmithKline Recent Development
11.2 Alitair Pharmaceuticals Inc.
11.2.1 Alitair Pharmaceuticals Inc. Company Detail
11.2.2 Alitair Pharmaceuticals Inc. Business Overview
11.2.3 Alitair Pharmaceuticals Inc. Bronchiectasis Therapeutic Introduction
11.2.4 Alitair Pharmaceuticals Inc. Revenue in Bronchiectasis Therapeutic Business (2018-2023)
11.2.5 Alitair Pharmaceuticals Inc. Recent Development
11.3 Bayer AG
11.3.1 Bayer AG Company Detail
11.3.2 Bayer AG Business Overview
11.3.3 Bayer AG Bronchiectasis Therapeutic Introduction
11.3.4 Bayer AG Revenue in Bronchiectasis Therapeutic Business (2018-2023)
11.3.5 Bayer AG Recent Development
11.4 Chiesi Farmaceutici SpA
11.4.1 Chiesi Farmaceutici SpA Company Detail
11.4.2 Chiesi Farmaceutici SpA Business Overview
11.4.3 Chiesi Farmaceutici SpA Bronchiectasis Therapeutic Introduction
11.4.4 Chiesi Farmaceutici SpA Revenue in Bronchiectasis Therapeutic Business (2018-2023)
11.4.5 Chiesi Farmaceutici SpA Recent Development
11.5 Grifols SA
11.5.1 Grifols SA Company Detail
11.5.2 Grifols SA Business Overview
11.5.3 Grifols SA Bronchiectasis Therapeutic Introduction
11.5.4 Grifols SA Revenue in Bronchiectasis Therapeutic Business (2018-2023)
11.5.5 Grifols SA Recent Development
11.6 Insmed Inc
11.6.1 Insmed Inc Company Detail
11.6.2 Insmed Inc Business Overview
11.6.3 Insmed Inc Bronchiectasis Therapeutic Introduction
11.6.4 Insmed Inc Revenue in Bronchiectasis Therapeutic Business (2018-2023)
11.6.5 Insmed Inc Recent Development
11.7 Kamada Ltd
11.7.1 Kamada Ltd Company Detail
11.7.2 Kamada Ltd Business Overview
11.7.3 Kamada Ltd Bronchiectasis Therapeutic Introduction
11.7.4 Kamada Ltd Revenue in Bronchiectasis Therapeutic Business (2018-2023)
11.7.5 Kamada Ltd Recent Development
11.8 Polyphor Ltd
11.8.1 Polyphor Ltd Company Detail
11.8.2 Polyphor Ltd Business Overview
11.8.3 Polyphor Ltd Bronchiectasis Therapeutic Introduction
11.8.4 Polyphor Ltd Revenue in Bronchiectasis Therapeutic Business (2018-2023)
11.8.5 Polyphor Ltd Recent Development
11.9 Recipharm AB
11.9.1 Recipharm AB Company Detail
11.9.2 Recipharm AB Business Overview
11.9.3 Recipharm AB Bronchiectasis Therapeutic Introduction
11.9.4 Recipharm AB Revenue in Bronchiectasis Therapeutic Business (2018-2023)
11.9.5 Recipharm AB Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Bronchiectasis Therapeutic Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Antibiotics
Table 3. Key Players of Expectorants
Table 4. Key Players of Others
Table 5. Global Bronchiectasis Therapeutic Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Bronchiectasis Therapeutic Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Bronchiectasis Therapeutic Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Bronchiectasis Therapeutic Market Share by Region (2018-2023)
Table 9. Global Bronchiectasis Therapeutic Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Bronchiectasis Therapeutic Market Share by Region (2024-2033)
Table 11. Bronchiectasis Therapeutic Market Trends
Table 12. Bronchiectasis Therapeutic Market Drivers
Table 13. Bronchiectasis Therapeutic Market Challenges
Table 14. Bronchiectasis Therapeutic Market Restraints
Table 15. Global Bronchiectasis Therapeutic Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Bronchiectasis Therapeutic Market Share by Players (2018-2023)
Table 17. Global Top Bronchiectasis Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bronchiectasis Therapeutic as of 2022)
Table 18. Ranking of Global Top Bronchiectasis Therapeutic Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Bronchiectasis Therapeutic Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Bronchiectasis Therapeutic Product Solution and Service
Table 22. Date of Enter into Bronchiectasis Therapeutic Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Bronchiectasis Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Bronchiectasis Therapeutic Revenue Market Share by Type (2018-2023)
Table 26. Global Bronchiectasis Therapeutic Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Bronchiectasis Therapeutic Revenue Market Share by Type (2024-2033)
Table 28. Global Bronchiectasis Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Bronchiectasis Therapeutic Revenue Market Share by Application (2018-2023)
Table 30. Global Bronchiectasis Therapeutic Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Bronchiectasis Therapeutic Revenue Market Share by Application (2024-2033)
Table 32. North America Bronchiectasis Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Bronchiectasis Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Bronchiectasis Therapeutic Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Bronchiectasis Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Bronchiectasis Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Bronchiectasis Therapeutic Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Bronchiectasis Therapeutic Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Bronchiectasis Therapeutic Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Bronchiectasis Therapeutic Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Bronchiectasis Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Bronchiectasis Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Bronchiectasis Therapeutic Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Bronchiectasis Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Bronchiectasis Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Bronchiectasis Therapeutic Market Size by Country (2024-2033) & (US$ Million)
Table 47. GlaxoSmithKline Company Detail
Table 48. GlaxoSmithKline Business Overview
Table 49. GlaxoSmithKline Bronchiectasis Therapeutic Product
Table 50. GlaxoSmithKline Revenue in Bronchiectasis Therapeutic Business (2018-2023) & (US$ Million)
Table 51. GlaxoSmithKline Recent Development
Table 52. Alitair Pharmaceuticals Inc. Company Detail
Table 53. Alitair Pharmaceuticals Inc. Business Overview
Table 54. Alitair Pharmaceuticals Inc. Bronchiectasis Therapeutic Product
Table 55. Alitair Pharmaceuticals Inc. Revenue in Bronchiectasis Therapeutic Business (2018-2023) & (US$ Million)
Table 56. Alitair Pharmaceuticals Inc. Recent Development
Table 57. Bayer AG Company Detail
Table 58. Bayer AG Business Overview
Table 59. Bayer AG Bronchiectasis Therapeutic Product
Table 60. Bayer AG Revenue in Bronchiectasis Therapeutic Business (2018-2023) & (US$ Million)
Table 61. Bayer AG Recent Development
Table 62. Chiesi Farmaceutici SpA Company Detail
Table 63. Chiesi Farmaceutici SpA Business Overview
Table 64. Chiesi Farmaceutici SpA Bronchiectasis Therapeutic Product
Table 65. Chiesi Farmaceutici SpA Revenue in Bronchiectasis Therapeutic Business (2018-2023) & (US$ Million)
Table 66. Chiesi Farmaceutici SpA Recent Development
Table 67. Grifols SA Company Detail
Table 68. Grifols SA Business Overview
Table 69. Grifols SA Bronchiectasis Therapeutic Product
Table 70. Grifols SA Revenue in Bronchiectasis Therapeutic Business (2018-2023) & (US$ Million)
Table 71. Grifols SA Recent Development
Table 72. Insmed Inc Company Detail
Table 73. Insmed Inc Business Overview
Table 74. Insmed Inc Bronchiectasis Therapeutic Product
Table 75. Insmed Inc Revenue in Bronchiectasis Therapeutic Business (2018-2023) & (US$ Million)
Table 76. Insmed Inc Recent Development
Table 77. Kamada Ltd Company Detail
Table 78. Kamada Ltd Business Overview
Table 79. Kamada Ltd Bronchiectasis Therapeutic Product
Table 80. Kamada Ltd Revenue in Bronchiectasis Therapeutic Business (2018-2023) & (US$ Million)
Table 81. Kamada Ltd Recent Development
Table 82. Polyphor Ltd Company Detail
Table 83. Polyphor Ltd Business Overview
Table 84. Polyphor Ltd Bronchiectasis Therapeutic Product
Table 85. Polyphor Ltd Revenue in Bronchiectasis Therapeutic Business (2018-2023) & (US$ Million)
Table 86. Polyphor Ltd Recent Development
Table 87. Recipharm AB Company Detail
Table 88. Recipharm AB Business Overview
Table 89. Recipharm AB Bronchiectasis Therapeutic Product
Table 90. Recipharm AB Revenue in Bronchiectasis Therapeutic Business (2018-2023) & (US$ Million)
Table 91. Recipharm AB Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bronchiectasis Therapeutic Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Bronchiectasis Therapeutic Market Share by Type: 2022 VS 2033
Figure 3. Antibiotics Features
Figure 4. Expectorants Features
Figure 5. Others Features
Figure 6. Global Bronchiectasis Therapeutic Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Bronchiectasis Therapeutic Market Share by Application: 2022 VS 2033
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Bronchiectasis Therapeutic Report Years Considered
Figure 12. Global Bronchiectasis Therapeutic Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Bronchiectasis Therapeutic Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Bronchiectasis Therapeutic Market Share by Region: 2022 VS 2033
Figure 15. Global Bronchiectasis Therapeutic Market Share by Players in 2022
Figure 16. Global Top Bronchiectasis Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bronchiectasis Therapeutic as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Bronchiectasis Therapeutic Revenue in 2022
Figure 18. North America Bronchiectasis Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Bronchiectasis Therapeutic Market Share by Country (2018-2033)
Figure 20. United States Bronchiectasis Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Bronchiectasis Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Bronchiectasis Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Bronchiectasis Therapeutic Market Share by Country (2018-2033)
Figure 24. Germany Bronchiectasis Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Bronchiectasis Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Bronchiectasis Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Bronchiectasis Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Bronchiectasis Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Bronchiectasis Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Bronchiectasis Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Bronchiectasis Therapeutic Market Share by Region (2018-2033)
Figure 32. China Bronchiectasis Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Bronchiectasis Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Bronchiectasis Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Bronchiectasis Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Bronchiectasis Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Bronchiectasis Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Bronchiectasis Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Bronchiectasis Therapeutic Market Share by Country (2018-2033)
Figure 40. Mexico Bronchiectasis Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Bronchiectasis Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Bronchiectasis Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Bronchiectasis Therapeutic Market Share by Country (2018-2033)
Figure 44. Turkey Bronchiectasis Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Bronchiectasis Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. GlaxoSmithKline Revenue Growth Rate in Bronchiectasis Therapeutic Business (2018-2023)
Figure 47. Alitair Pharmaceuticals Inc. Revenue Growth Rate in Bronchiectasis Therapeutic Business (2018-2023)
Figure 48. Bayer AG Revenue Growth Rate in Bronchiectasis Therapeutic Business (2018-2023)
Figure 49. Chiesi Farmaceutici SpA Revenue Growth Rate in Bronchiectasis Therapeutic Business (2018-2023)
Figure 50. Grifols SA Revenue Growth Rate in Bronchiectasis Therapeutic Business (2018-2023)
Figure 51. Insmed Inc Revenue Growth Rate in Bronchiectasis Therapeutic Business (2018-2023)
Figure 52. Kamada Ltd Revenue Growth Rate in Bronchiectasis Therapeutic Business (2018-2023)
Figure 53. Polyphor Ltd Revenue Growth Rate in Bronchiectasis Therapeutic Business (2018-2023)
Figure 54. Recipharm AB Revenue Growth Rate in Bronchiectasis Therapeutic Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed